The Lundquist Institute has led or participated in eight COVID-19 clinical studies whose results have changed the world.
Watch a recording of our webinar from March 10, 2021, featuring The Lundquist Institute's expert clinician investigators.
Formulation will be developed by the Gates MRI to treat respiratory distress syndrome for premature infants.
Institute researchers discovered a natural compound that exhibits almost ideal male contraceptive effects in pre-clinical studies.
The grant will fund clinical trials to study the efficacy of psilocybin in treating the emotional suffering associated with terminal medical illness.
This will accelerate the development of new therapies, medical devices, and diagnostics.
A place for the community to submit their questions to our institute's investigators and innovators.